← Browse by Condition
Medical Condition
psychedelic experiences
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
ClinicalMetric aggregates all active clinical trials for psychedelic experiences from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.
- Recruiting trials — currently enrolling participants, with eligibility criteria
- Phase 1–4 studies — from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary for every trial listing
NCT06450210 Phase 1
Recruiting
Safety for Home Administration of Microdose Psilocybin Use
Enrollment
20 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06927076
Recruiting
Antidepressant Response of DMT Masked With Propofol
Enrollment
112 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...